Learn More
A phase II prospective, randomized, double blind clinical trial of Bradycor, a bradykinin antagonist, was conducted at 31 centers within North America in severely brain injured patients. Patients of(More)
“We followed a few years after Mr. Swift. We had to learn the methods of dressed beef and experiment. The methods have been gradually growing. We have perfected them year by year, learning something(More)